Specifications
Immunogen
E. coli-derived recombinant human Lymphotoxin-alpha /TNF-beta, Leu35-Leu205, Accession #P01374
Applications
Application Notes
WB: 0.1 μg/mL, we recommend the following for sandwich ELISA (Capture-Detection): CABT-L221-CABT-L222
Target
Alternative Names
LT; LTA; LT-alpha; lymphotoxin alpha (TNF superfamily; member 1); Lymphotoxin alpha; Lymphotoxinalpha; Lymphotoxin-alpha; tnfb; TNF-beta; TNFBlymphotoxin-alpha; TNFSF1; TNFSF1B; TNFSF1TNF-beta; tumor necrosis factor beta; Tumor necrosis factor ligand superfamily member 1
Citations
Have you cited CABT-L222 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Hogendorf, WFJ; Gisch, N; et al. Total Synthesis of Five Lipoteichoic acids of Clostridium difficile. CHEMISTRY-A EUROPEAN JOURNAL 20:13511-13516(2014).
Esteves, LM; Bulhoes, SM; et al. Human Leptospirosis: Seroreactivity and Genetic Susceptibility in the Population of Sao Miguel Island (Azores, Portugal). PLOS ONE 9:-(2014).
COA
Certificate of Analysis![Human Anti-Human Lymphotoxin alpha (Pateclizumab) Monoclonal Antibody, clone MLTA3698A [Biosimilar] (CABT-Z681H)](https://img2.creative-diagnostics.com/productimage/CABT-Z681H_1.jpg)
